Formulation for treating thalassemia and a process for preparing the same
AssigneeCouncil of Scientific and Industrial Research
InventorsSarkar Ajit Kumar, Kumar Sudarshan, Priyadarshi Harsh, Khanna Sushil Rattan, Dass Ghansham
Life of this patent
Estimating the term…
Abstract
A pharmaceutical formulation useful for treating patients suffering from thalassemia, which comprises powder of Anemonin Pretensis in an amount in the range of 0.02 to 0.12 wt % of the formulation, quinine sulphate in an amount in the range of 0.0005 to 0.003 wt % of the formulation, distilled or demineralised water in an amount in the range of 0 to 40 wt % of the formulation and, ethanol in an amount in the range of 99.88 to 60 wt % of the formulation; and a process for preparing the formulation by mixing the above ingredients.
Claims10
A pharmaceutical formulation for treating patients suffering from thalassemia which comprises:
- a. powder of Anemonin Pretensis in an amount in the range of 0.02 to 0.12 wt % of the formulation,
- b. quinine sulphate in an amount in the range of 0.0005 to 0.003 wt % of the formulation,
- c. distilled or demineralized water in an amount in the range of 0 to 40 wt % of the formulation and
- d. ethanol in an amount in the range of 99.88 to 60 wt % of the formulation.
A process for the preparation of a pharmaceutical composition for treating patients suffering from Thalassemia, said process comprising mixing:
- a. powder of Anemonin Pretensis in an amount in the range of 0.02 to 0.12 wt % of the formulation,
- b. quinine sulphate in an amount in the range of 0.0005 to 0.003 wt % of the formulation,
- c. distilled or demineralized water in an amount in the range of 0 to 40 wt % of the formulation, and
- d. ethanol in an amount in the range of 99.8 to 60 wt % of the formulation.
A pharmaceutical formulation for treating patients suffering from thalassemia which comprises:
- a. Powder of Anemonin Pretensis in an amount of 0.08 wt % of the formulation,
- b. Quinine sulphate in an amount 0.001 wt % of the formulation,
- c. Water in an amount of 40 wt %, and
- d. Ethanol is an amount of 59.919 wt % of the formulation.
A pharmaceutical formulation for treating patients suffering from thalassemia which comprises:
- a. Powder of Anemonin Pretensis in an amount of 0.09 wt % of the formulation,
- b. Quinine sulphate in an amount 0.001 wt % of the formulation,
- c. Water in an amount 80 wt % of the formulation and
- d. Ethanol in an amount of 19.909 wt % of the formulation.
Dependencies are inferred from the claim text.